Clinical Trials Browser

Phase 3 × Active not recruiting × palbociclib × Clear all

NCT03425838 2026-05-20

Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

Phase 3 Active not recruiting

1,050 enrolled

Breast

Breast Neoplasm Female

NCT04546009 2026-05-19

A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)

Phase 3 Active not recruiting

992 enrolled

Breast

Breast Neoplasms

NCT06760637 2026-05-19

FourLight-3

Phase 3 Active not recruiting

1,035 enrolled

Breast

Unilateral Breast Neoplasms, Breast Neoplasms, Recurrence

NCT04964934 2026-04-21

SERENA-6

Phase 3 Active not recruiting

315 enrolled

Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site

NCT03820830 2026-04-09

POLAR

Phase 3 Active not recruiting

405 enrolled

Breast

Breast Cancer Recurrent

NCT02947685 2026-02-12

PATINA

Phase 3 Active not recruiting

518 enrolled 15 charts

Breast

Breast Neoplasms

NCT02513394 2026-02-10

PALLAS

Phase 3 Active not recruiting

5,796 enrolled 14 charts

Breast

Breast Neoplasms

NCT05501886 2026-02-10

VIKTORIA-1

Phase 3 Active not recruiting

701 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT05909397 2026-02-10

VERITAC-3

Phase 3 Active not recruiting

59 enrolled

Breast

Breast Neoplasms

NCT04711252 2025-10-14

SERENA-4

Phase 3 Active not recruiting

1,370 enrolled

Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Skin Diseases

NCT05207709 2025-04-29

HARMONIA

Phase 3 Active not recruiting

456 enrolled

Breast

Breast Neoplasms